Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-01-31 Purchase |
2022-02-01 5:04 pm |
Sierra Oncology Inc. | SRRA | Sinclair Andrew Director |
150,000 | $27 | $4,050,000 | 1,314,127 (Indirect) |
View |
| 2022-01-31 Purchase |
2022-02-01 5:00 pm |
Sierra Oncology Inc. | SRRA | Abingworth LLP 10% Owner |
150,000 | $27 | $4,050,000 | 1,314,127 (Indirect) |
View |
| 2022-01-31 Purchase |
2022-01-31 9:30 pm |
Sierra Oncology Inc. | SRRA | Vivo Opportunity LLC Vivo Opportunity Fund L.P. Vivo Capital IX LLC Vivo Capital Fund IX L.P. VIVO VENTURES VII LLC Vivo Ventures Fund VII L.P. Vivo Ventures VII Affiliates Fund L.P. 10% Owner |
800,000 | $27 | $21,600,000 | 3,329,512 (Indirect) |
View |
| 2022-01-31 Purchase |
2022-01-31 6:47 pm |
Sierra Oncology Inc. | SRRA | Aggarwal Gaurav Director 10% Owner |
800,000 | $27 | $21,600,000 | 2,735,853 (Indirect) |
View |
| 2022-01-26 Sale |
2022-01-28 4:47 pm |
Sierra Oncology Inc. | SRRA | Thomson Mary Christina General Counsel & Secretary |
2,000 | $29 | $58,000 | 12,250 (Direct) |
View |
| 2022-01-26 Sale |
2022-01-28 4:39 pm |
Sierra Oncology Inc. | SRRA | Turner William D. Chief Reg & Tech Ops Officer |
5,000 | $27.05 | $135,250 | 12,250 (Direct) |
View |
| 2021-11-23 Purchase |
2021-11-24 7:07 pm |
Sierra Oncology Inc. | SRRA | Collard Craig A Director |
13,500 | $23.03 | $310,863 | 13,500 (Direct) |
View |
| 2021-05-19 Purchase |
2021-05-20 6:59 pm |
Sierra Oncology Inc. | SRRA | DILLY STEPHEN GEORGE CEO and President |
5,000 | $17.83 | $89,150 | 5,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-28 Exercise |
2022-02-01 5:04 pm |
2020-01-22 N/A |
Sierra Oncology Inc. | SRRA | Sinclair Andrew Director |
287,471 | $0 | 1,314,127 (Indirect) |
View |
| 2022-01-28 Exercise |
2022-02-01 5:04 pm |
N/A N/A |
Sierra Oncology Inc. | SRRA | Sinclair Andrew Director |
287,471 | $13.2 | 1,314,127 (Indirect) |
View |
| 2022-01-28 Exercise |
2022-02-01 5:00 pm |
2020-01-22 N/A |
Sierra Oncology Inc. | SRRA | Abingworth LLP 10% Owner |
287,471 | $0 | 1,314,127 (Indirect) |
View |
| 2022-01-28 Exercise |
2022-02-01 5:00 pm |
N/A N/A |
Sierra Oncology Inc. | SRRA | Abingworth LLP 10% Owner |
287,471 | $13.2 | 1,314,127 (Indirect) |
View |
| 2022-01-26 Exercise |
2022-01-28 9:23 pm |
2020-01-22 N/A |
Sierra Oncology Inc. | SRRA | Ashiya Mona Director 10% Owner |
487,450 | $0 | 226,704 (Indirect) |
View |
| 2022-01-26 Exercise |
2022-01-28 9:23 pm |
N/A N/A |
Sierra Oncology Inc. | SRRA | Ashiya Mona Director 10% Owner |
431,206 | $13.2 | 226,704 (Indirect) |
View |
| 2022-01-26 Exercise |
2022-01-28 9:22 pm |
2020-01-22 N/A |
Sierra Oncology Inc. | SRRA | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC OrbiMed Genesis GP LLC Director 10% Owner |
487,450 | $0 | 226,704 (Indirect) |
View |
| 2022-01-26 Exercise |
2022-01-28 9:22 pm |
N/A N/A |
Sierra Oncology Inc. | SRRA | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC OrbiMed Genesis GP LLC Director 10% Owner |
431,206 | $13.2 | 226,704 (Indirect) |
View |
| 2022-01-26 Exercise |
2022-01-28 8:12 pm |
2020-01-22 N/A |
Sierra Oncology Inc. | SRRA | Vivo Opportunity LLC Vivo Opportunity Fund L.P. Vivo Capital IX LLC Vivo Capital Fund IX L.P. VIVO VENTURES VII LLC Vivo Ventures Fund VII L.P. Vivo Ventures VII Affiliates Fund L.P. 10% Owner |
2,468,310 | $13.2 | 431,947 (Indirect) |
View |
| 2022-01-26 Exercise |
2022-01-28 7:53 pm |
2020-01-22 N/A |
Sierra Oncology Inc. | SRRA | Aggarwal Gaurav Director 10% Owner |
1,935,661 | $13.2 | 1,935,853 (Indirect) |
View |
| 2022-01-28 Option Award |
2022-01-28 6:34 pm |
2022-01-28 2030-08-12 |
Sierra Oncology Inc. | SRRA | Klencke Barbara Chief Medical Officer |
12,250 | $0 | 12,250 (Direct) |
View |
| 2022-01-28 Option Award |
2022-01-28 6:34 pm |
2022-01-28 2030-08-12 |
Sierra Oncology Inc. | SRRA | Kowalski Mark Chief, Research & Early Dev |
12,250 | $0 | 12,250 (Direct) |
View |
| 2022-01-28 Option Award |
2022-01-28 6:33 pm |
2022-01-28 2030-08-12 |
Sierra Oncology Inc. | SRRA | Norrett Kevin Chief Business Officer |
12,250 | $0 | 12,250 (Direct) |
View |
| 2022-01-28 Option Award |
2022-01-28 6:32 pm |
2022-01-28 2030-08-12 |
Sierra Oncology Inc. | SRRA | DILLY STEPHEN GEORGE CEO and President |
65,000 | $0 | 65,000 (Direct) |
View |
| 2022-01-28 Option Award |
2022-01-28 6:31 pm |
2022-01-28 2030-08-12 |
Sierra Oncology Inc. | SRRA | Jagpal Sukhi Chief Financial Officer |
12,250 | $0 | 12,250 (Direct) |
View |
| 2022-01-28 Option Award |
2022-01-28 4:47 pm |
2022-01-28 2030-08-12 |
Sierra Oncology Inc. | SRRA | Thomson Mary Christina General Counsel & Secretary |
12,250 | $0 | 12,250 (Direct) |
View |
| 2022-01-26 Exercise |
2022-01-28 4:47 pm |
N/A 2030-07-28 |
Sierra Oncology Inc. | SRRA | Thomson Mary Christina General Counsel & Secretary |
2,000 | $0 | 12,250 (Direct) |
View |
| 2022-01-26 Exercise |
2022-01-28 4:47 pm |
N/A N/A |
Sierra Oncology Inc. | SRRA | Thomson Mary Christina General Counsel & Secretary |
2,000 | $13.04 | 12,250 (Direct) |
View |
| 2022-01-28 Option Award |
2022-01-28 4:39 pm |
2022-01-28 2030-08-12 |
Sierra Oncology Inc. | SRRA | Turner William D. Chief Reg & Tech Ops Officer |
12,250 | $0 | 12,250 (Direct) |
View |
| 2022-01-26 Exercise |
2022-01-28 4:39 pm |
N/A 2030-08-04 |
Sierra Oncology Inc. | SRRA | Turner William D. Chief Reg & Tech Ops Officer |
5,000 | $0 | 12,250 (Direct) |
View |
| 2022-01-26 Exercise |
2022-01-28 4:39 pm |
N/A N/A |
Sierra Oncology Inc. | SRRA | Turner William D. Chief Reg & Tech Ops Officer |
5,000 | $12.05 | 12,250 (Direct) |
View |
| 2022-01-25 Exercise |
2022-01-27 9:23 pm |
2020-01-22 2022-04-10 |
Sierra Oncology Inc. | SRRA | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
1,964,576 | $13.2 | 1,964,771 (Indirect) |
View |
| 2022-01-25 Exercise |
2022-01-27 9:22 pm |
2020-01-22 2022-04-10 |
Sierra Oncology Inc. | SRRA | Richardson Joshua Director 10% Owner |
1,964,576 | $13.2 | 1,964,771 (Indirect) |
View |
Ownership |
2021-11-05 4:44 pm |
N/A N/A |
Sierra Oncology Inc. | SRRA | Abingworth LLP 10% Owner |
0 | $0 | 2,051,626 (Indirect) |
View |
| 2021-03-15 Option Award |
2021-06-28 9:34 pm |
N/A 2031-03-15 |
Sierra Oncology Inc. | SRRA | Thomson Mary Christina General Counsel |
12,900 | $0 | 12,900 (Direct) |
View |
| 2020-07-28 Option Award |
2021-06-28 9:27 pm |
N/A 2030-07-28 |
Sierra Oncology Inc. | SRRA | Thomson Mary Christina General Counsel |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-09 10:52 am |
N/A 2031-06-08 |
Sierra Oncology Inc. | SRRA | Cooper Jeffrey H Director |
6,000 | $0 | 6,000 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-09 10:50 am |
N/A 2031-06-08 |
Sierra Oncology Inc. | SRRA | Collard Craig A Director |
6,000 | $0 | 6,000 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-09 10:38 am |
N/A 2031-06-08 |
Sierra Oncology Inc. | SRRA | Pelzer Robert Director |
6,000 | $0 | 6,000 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-09 10:36 am |
N/A 2031-06-08 |
Sierra Oncology Inc. | SRRA | Ashiya Mona Director 10% Owner |
6,000 | $0 | 6,000 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-09 10:31 am |
N/A 2031-06-08 |
Sierra Oncology Inc. | SRRA | Allen Andrew R Director |
6,000 | $0 | 6,000 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-09 10:29 am |
N/A 2031-06-08 |
Sierra Oncology Inc. | SRRA | Aggarwal Gaurav Director 10% Owner |
6,000 | $0 | 6,000 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-09 10:24 am |
N/A 2031-06-08 |
Sierra Oncology Inc. | SRRA | Sinclair Andrew Director |
6,000 | $0 | 6,000 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-09 10:19 am |
N/A 2031-06-08 |
Sierra Oncology Inc. | SRRA | Richardson Joshua Director 10% Owner |
6,000 | $0 | 6,000 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 1:59 pm |
N/A 2031-06-02 |
Sierra Oncology Inc. | SRRA | Oliger Christy J. Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 10:48 am |
N/A 2031-06-02 |
Sierra Oncology Inc. | SRRA | Erbez Georgia Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2021-03-15 Option Award |
2021-03-17 9:18 pm |
N/A 2031-03-15 |
Sierra Oncology Inc. | SRRA | Turner William D. Chief Reg & Tech Ops Officer |
12,300 | $0 | 12,300 (Direct) |
View |
| 2021-03-15 Option Award |
2021-03-17 9:18 pm |
N/A 2031-03-15 |
Sierra Oncology Inc. | SRRA | Thomson Christina General Counsel |
12,900 | $0 | 12,900 (Direct) |
View |
| 2021-03-15 Option Award |
2021-03-17 9:17 pm |
N/A 2031-03-15 |
Sierra Oncology Inc. | SRRA | Norrett Kevin Chief Business Officer |
11,700 | $0 | 11,700 (Direct) |
View |
| 2021-03-15 Option Award |
2021-03-17 9:16 pm |
N/A 2031-03-15 |
Sierra Oncology Inc. | SRRA | Kowalski Mark Chief Medical Officer |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-03-15 Option Award |
2021-03-17 9:15 pm |
N/A 2031-03-15 |
Sierra Oncology Inc. | SRRA | Klencke Barbara Chief Development Officer |
30,000 | $0 | 30,000 (Direct) |
View |